Pear claims breakthrough tag for alcohol use disorder DTxDigital health company Pear Therapeutics has won FDA breakthrough device status for reSET-A, its development-stage prescription digital therapeutic Share XPear claims breakthrough tag for alcohol use disorder DTxhttps://pharmaphorum.com/news/pear-claims-breakthrough-tag-for-alcohol-use-disorder-dtx/
Orexo partners with Lyfebulb to study addiction during pandemicWith drinking and drug use said to be spiking during the pandemic, Orexo has teamed up with US Share XOrexo partners with Lyfebulb to study addiction during pandemichttps://pharmaphorum.com/news/orexo-partners-with-lyfebulb-to-study-addiction-during-pandemic/
Orexo eyes launch of digital therapy for heavy drinkers this yearOrexo has submitted its Vorvida digital therapy for the treatment of heavy drinking for approval by the FDA, Share XOrexo eyes launch of digital therapy for heavy drinkers this yearhttps://pharmaphorum.com/news/orexo-eyes-launch-of-digital-therapy-for-heavy-drinkers-this-year/
Addiction firm Orexo licenses app for alcohol use disorderSwedish drugmaker Orexo, best known for its opioid addiction therapies, has licensed rights to a digital therapy that Share XAddiction firm Orexo licenses app for alcohol use disorderhttps://pharmaphorum.com/news/addiction-firm-orexo-licenses-app-for-alcohol-use-disorder/
